Effects of Sulforaphane on Normal Prostate Tissue
- Conditions
- Prostate Cancer
- Interventions
- Drug: High Sulforaphane Extract (Broccoli Sprout Extract)Drug: Microcrystalline Cellulose NF (placebo)
- Registration Number
- NCT00946309
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Brief Summary
The investigators proposed to identify the biological effects of a high-sulforaphane broccoli sprout extract in normal prostate tissue.
The investigators hypothesize that consumption of high-sulforaphane broccoli sprout extract every other day will inhibit growth of prostate cancer cells.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 45
- Men aged 40-75 years
- Low or intermediate grade prostate cancer (as defined by Gleason sum less than or equal to 7) and clinical stage T1 or T2
- Serum Prostate specific antigen less than 20 ng/ml
- Have elected radical prostatectomy, Brachytherapy or active surveillance as their primary treatment
- No current physician diagnosed disease (including but not limited to): kidney disease requiring dialysis, cognitive deficits, substance abuse
- BMI < 18.5 kg/m2 or > 40 kg/m2
- Use of any hormonal treatments, including but not limited to testosterone
- Any previous cancer diagnosis or treatment within the previous five years, excluding non-melanoma skin cancer
- Inability or unwillingness to eat a diet that is free of Brassica vegetables for the duration of the study
- Use of any dietary supplements other than a multivitamin (including herbal preparations)
- Allergy to cruciferous vegetables or any of the specific fillers used in the placebo
- Usual consumption of > 5 servings per week of Brassica vegetables
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description High Sulforaphane Extract High Sulforaphane Extract (Broccoli Sprout Extract) - Placebo Microcrystalline Cellulose NF (placebo) -
- Primary Outcome Measures
Name Time Method Gene Expression of Phase II Enzymes Baseline and 5 weeks Change in Phase II enzyme expression
DHT Levels Baseline and 5 weeks Change in serum dihydrotestosterone (DHT) levels
Testosterone Levels Baseline and 5 weeks Change in testosterone (T) levels
DNA Oxidation Five weeks Prostate tissue 8-hydroxy-2'-deoxyguanosine (8OHdG) levels
Lipid Oxidation Baseline and 5 weeks Blood F2 Isoprostane levels
3-alpha-diol Gluconate Levels Baseline and 5 weeks Change in serum 3-alpha-diol gluconate(3α-DG) levels
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
VA Puget Sound
🇺🇸Seattle, Washington, United States